Omeros Co. (NASDAQ:OMER – Free Report) – Equities researchers at Cantor Fitzgerald decreased their FY2024 earnings per share estimates for Omeros in a note issued to investors on Thursday, May 16th. Cantor Fitzgerald analyst O. Brayer now expects that the biopharmaceutical company will post earnings per share of ($1.81) for the year, down from their […]
Omeros Co. (NASDAQ:OMER – Free Report) – Equities researchers at Cantor Fitzgerald cut their FY2024 EPS estimates for Omeros in a research report issued on Thursday, May 16th. Cantor Fitzgerald analyst O. Brayer now anticipates that the biopharmaceutical company will post earnings per share of ($1.81) for the year, down from their previous forecast of […]